Letter to Editor Coronavirus disease 2019 (COVID-19) was first declared in December 2019 from Wuhan, China [1, 2]. It then has been reported a pandemic in March 2020 by the World Health Organization [3]. Clinical features of COVID-19 are different from asymptomatic to mild to moderate symptoms, such as fever, headache, myalgia, sore throat, anosmia, cough, fatigue headache, hemoptysis, and dyspnea to the life-threatening complications, including shock, pneumonia, acute respiratory distress syndrome, myocarditis, myocardial infarction, acute kidney injury, multi-organ failure, and even death [1, 2]. One of the possible routes for central nervous system (CNS) involvement by COVID-19 is diffusing through the respiratory tract to the olfactory bulb and the formation of blood clots in the CNS [1, 4]. COVID-19 has been associated with neurological complications, such as anosmia, stroke, paralysis, cranial nerve deficits, encephalopathy, delirium, transient ischemic attack, meningitis, acute stroke, encephalitis, and seizures...